US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
アメリカ
USOTC
Kobe Bussan Company Ltd (PK) (KOBNF) 銘柄情報

Kobe Bussan Company Ltd (PK) (KOBNF)

24.10

0.00

(0.00%)

終了 6月14日 5:00AM

Kobe Bussan Company Ltd (PK) (KOBNF) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

24.10

( - )

買値

12.60

売値

37.27

出来高

-

0.00 日の範囲 0.00

24.10 52 週間の範囲 29.57

時価総額

前日終値

24.10

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

US$ 1,779,089

発行済株式数

221,763,141

配当利回り

26 (1.21%)

PER

21.9

1 株当たり利益 (EPS)

122.06

歳入

560.87B

純利益

27.2B

Kobe Bussan Co., Ltd. primarily engages in the manufacture, wholesale, and retail food products, and franchise supermarket chain in Japan. The company offers a range of food products through its Gyomu superstores. It also operates a chain of buffet restaurants under the Kobe Cook World Buffet brand;... Kobe Bussan Co., Ltd. primarily engages in the manufacture, wholesale, and retail food products, and franchise supermarket chain in Japan. The company offers a range of food products through its Gyomu superstores. It also operates a chain of buffet restaurants under the Kobe Cook World Buffet brand; a chain of served a-la-carte buffet style BBQ restaurants under the Premium Karubi brand; and a chain of delicatessen shops under the concept of offering everyday dining under the CHISOUNA brand. In addition, the company operates and manages renewable energy power plants, including solar and woody biomass power plants. Kobe Bussan Co., Ltd. was founded in 1981 and is headquartered in Kakogawa, Japan. 詳細を表示

セクター

Consumer Staples

業界

Retailers - Staples

ウェブサイト

www.kobebussan.co.jp

本社

Kakogawa, Japan

設立

1981

Kobe Bussan Company Ltd (PK) is listed in the Consumer Staples sector of the その他OTC with ticker KOBNF. The last closing price for Kobe Bussan (PK) was US$24.10. Over the last year, Kobe Bussan (PK) shares have traded in a share price range of US$ 24.10 to US$ 29.57.

Kobe Bussan (PK) currently has 221,763,141 shares in issue. The market capitalisation of Kobe Bussan (PK) is US$5.34 billion. Kobe Bussan (PK) has a price to earnings ratio (PE ratio) of 21.90.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	24.1	24.1	24.1	0	0	CS
26	0	0	24.1	24.1	24.1	0	0	CS
52	-5.47	-18.4984781874	29.57	29.57	24.1	30	28.65833333	CS
156	-4.18	-14.7807637907	28.28	31.81014	21.3204	172	30.976484	CS
260	2.64	12.3019571295	21.46	31.81014	21.3204	183	29.35460909	CS

KOBNF - Frequently Asked Questions (FAQ)

What is the current Kobe Bussan Company Ltd (PK) share price?

The current share price of Kobe Bussan Company Ltd (PK) is US$ 24.10

How many Kobe Bussan Company Ltd (PK) shares are in issue?

Kobe Bussan Company Ltd (PK) has 221,763,141 shares in issue

What is the market cap of Kobe Bussan Company Ltd (PK)?

The market capitalisation of Kobe Bussan Company Ltd (PK) is USD 5.34B

What is the 1 year trading range for Kobe Bussan Company Ltd (PK) share price?

Kobe Bussan Company Ltd (PK) has traded in the range of US$ 24.10 to US$ 29.57 during the past year

What is the PE ratio of Kobe Bussan Company Ltd (PK)?

The price to earnings ratio of Kobe Bussan Company Ltd (PK) is 21.9

What is the cash to sales ratio of Kobe Bussan Company Ltd (PK)?

The cash to sales ratio of Kobe Bussan Company Ltd (PK) is 1.06

What is the registered address of Kobe Bussan Company Ltd (PK)?

The registered address for Kobe Bussan Company Ltd (PK) is 125-1 Hirano, Kakogawa, Hyogo, 675-0063

What is the Kobe Bussan Company Ltd (PK) website address?

The website address for Kobe Bussan Company Ltd (PK) is www.kobebussan.co.jp

Which industry sector does Kobe Bussan Company Ltd (PK) operate in?

Kobe Bussan Company Ltd (PK) operates in the Retailers - Staples sector

EZ2

11-12-22-24. 🙏

FlashySage44

FlashySage44 9分前

The day of reckoning is coming.
Two and a half weeks until the Next ER.
8 and a half until the August one.
No buyout in sight.
When will the longs start to question the buyout not happening?
I am very interested to see what this place will be saying come September

FlashySage44

FlashySage44 27分前

You’re not wolv?

jay_tee

jay_tee 44分前

That “yup still there” has to be the most asinine post ever. Where else would worthless paper/digital em shares be? Sure the shares are there BUT Seamus has taken its value and poured it into FOXO. He played us all well at least up to this point….safe shares sitting at .000001 is toilet paper

doogdilinger

doogdilinger 53分前

Right place at the right time BERK buddy:

joe_techi

joe_techi 1時間前

The Rolling Stones - 2000 Light Years From Home
https://www.youtube.com/watch?v=RLhFT7YXnoI

xoom

xoom 1時間前

Exactly. Please ask your bosses to distribute shares asap..
Please ask your bosses to learn from Musk and how he treats his folks aka SpaceX shareholders.

Frankestin

Frankestin 1時間前

https://youtu.be/iH3oOVKt0WI?is=6VNcgxb-14JC0yZD

gregcod

gregcod 1時間前

Is july going to be IBATs Month?

rodeoup

rodeoup 2時間前

Spot on. This will be the best summer this company has ever had in my book!!!

Dragonman1

Dragonman1 2時間前

please send me the email

satter

satter 3時間前

Unless he is going to announce he is receiving some major investment, capital, nothing is going to change. Eric will just make it sound like some big change coming with his master of loaded words. And unfortunately once again you'll fall for it. Even after Eric mislead, misrepresented, again, how gr

US Market News

US Market News 3時間前

Lilly's Jaypirca (pirtobrutinib) significantly reduced the risk of disease progression or death by 45% when added to a venetoclax time-limited regimen in people with previously treated CLL/SLLJune 14, 2026 3:15 AM
PR Newswire (US) BRUIN C

eagle8

eagle8 3時間前

Andrew Caravello, DO reposted
RJM
@rjmsoflo
The Day After Approval

Strategically Dangerous

$NWBO

What does NWBO look like to serious money the day after approval?

Because right now… the market sees OTC, delays, dilution

t1215s

t1215s 3時間前

Good morning people, There are. Others that could use that monies without a doubt for whatever their needs are , As for me ,I never really counted on it,hence my iffen on topic of returns , but I sure as heck would enjoying spending it and giving some away for sure ,as my life is just fine the way

Investor2014

Investor2014 4時間前

Terrie should go for $1249 and call it quits.

Tr8dervic

Tr8dervic 4時間前

I'm in with 5 11 24 19

Dave has 5 24 19 11

Waiting on Stephen

mrwrn2010

mrwrn2010 4時間前

“WHEREAS, Elite Laboratories, Inc., intends to amend ANDA No. 217939…”

I take that to mean they are just flipping to P3 and not starting from scratch. Question is how much review has the FDA done on this ANDA to date? And does the 30-month stay only affect final approval, or does it b

europa7

europa7 4時間前

Dell Technologies to Bring Grok SpaceXAI Models On-Premises to Enterprise Environments
"...Dell and SpaceXAI bring Grok AI models on-premises, giving enterprises advanced AI with complete data control and security..."
May 18, 2026
https://www.dell.com/en-us/blog/dell-technologie

Just give me $1.50

Just give me $1.50 4時間前

Does anybody know the answer to this question?

1. Does Elite have to submit a brand new Paragraph 3 filing for Generic OxyContin, meaning they'll have to wait the full 10 months for a Tentative Approval. Or can we just switch it from Paragraph 4 to Paragraph 3 with someone paperwor

Just give me $1.50

Just give me $1.50 4時間前

1. How do you know that isn't standard boilerplate language? In other words, every company in the same/similar situation does the exact same thing. Similar to 10-K's for publicly traded companies, literally every possible scenario and warning is listed in there.

2. What are the

barnstormer

barnstormer 4時間前

082, if she had ever said that there would be a record somewhere on file. You're good at making up supposed statements but as usual when pushed for support of your statement there isn't anything to be found. That's pretty par for the course with your act. Make up a story or accusation without suppor

Kobe Bussan (PK)

ETFS 3x Long JPY Short USD

6.375% 11apr2031

Americas Uranium

VanEck Investments

Element Lifestyle Retire...

Bionano Genomics

Goodyear Tire & Rubber

Xtrackers MSCI Japan UCI...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。